← Back to headlines
Definium Therapeutics Stock Poised for Gains After Positive Emerge Trial Update
Definium Therapeutics, Inc. (DFTX) stock is being evaluated for further gains following a positive update from its Emerge trial.
30 Jun, 13:21 — 30 Jun, 13:21
Sources
Showing 1 of 1 sources
Related Stories
US Envoys Arrive in Moscow for Ukraine Peace Talks Amid Russian Airport Strikes
6m ago
Trump’s Special Envoys Arrive in Moscow Ahead of Ukraine Peace Talks
17m ago
Masked Anti-Migrant Protesters Blockade Port of Dover, Causing Traffic Chaos
20m ago
UN General Assembly Approves New World Map Accurately Reflecting Africa’s Size
26m ago